Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7,426	8,270	17,184	6,332	50,569	17,806
Short-Term Investments	740.05	2,740	5,250	340.19	360.19	745
Trading Asset Securities	-	-	2.19	1,886	2,856	5,866
Cash & Short-Term Investments	8,166	11,010	22,437	8,558	53,786	24,417
Cash Growth	-18.80%	-50.93%	162.17%	-84.09%	120.28%	77.99%
Accounts Receivable	13,842	12,999	10,582	7,726	8,174	10,153
Other Receivables	245.73	208.85	729.74	194.11	509.92	1,774
Receivables	14,088	13,208	12,772	8,760	15,884	16,978
Inventory	12,555	8,920	12,897	13,019	10,546	16,977
Prepaid Expenses	117.74	134.45	139.83	116.21	80.58	129.48
Other Current Assets	785.06	1,164	326.62	654.81	408.36	294.83
Total Current Assets	35,712	34,436	48,572	31,108	80,705	58,796
Property, Plant & Equipment	49,639	48,794	64,529	93,526	96,943	101,312
Long-Term Investments	672.58	871.97	1,659	9,416	11,001	22,675
Goodwill	-	-	1,601	2,858	2,858	4,150
Other Intangible Assets	652.23	425.92	1,829	2,381	2,980	3,081
Long-Term Accounts Receivable	15.82	-	83.93	-	-	-
Long-Term Deferred Tax Assets	-	-	1,172	774.48	530.59	-
Long-Term Deferred Charges	-	-	5,030	9,020	9,701	8,622
Other Long-Term Assets	4,647	4,661	8,526	17,144	18,412	16,794
Total Assets	91,631	90,500	133,618	166,844	224,121	215,448

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	17,836	8,166	6,685	7,291	6,461	6,155
Accrued Expenses	520.9	513.9	700.15	755.32	718.82	496.54
Short-Term Debt	19,000	20,540	32,169	56,276	73,521	10,050
Current Portion of Long-Term Debt	1,019	1,019	1,556	12,766	3,747	32,120
Current Portion of Leases	1,042	1,311	1,234	77.56	171.09	185.44
Current Unearned Revenue	-	-	242.6	106.08	23.75	-
Other Current Liabilities	15,649	23,916	21,747	15,774	25,339	5,811
Total Current Liabilities	55,067	55,466	64,333	93,045	109,981	54,818
Long-Term Debt	222.21	666.63	4,352	4,862	9,450	31,650
Long-Term Leases	3,917	4,118	1,129	34.72	120.83	180.31
Pension & Post-Retirement Benefits	905.52	508.82	-	5,907	2,878	2,465
Long-Term Deferred Tax Liabilities	-	-	-	-	-	16.36
Other Long-Term Liabilities	2,211	2,220	2,112	2,852	9,833	27,615
Total Liabilities	62,323	62,980	71,927	106,700	132,262	116,744

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	18,779	18,779	18,779	18,779	18,779	9,446
Additional Paid-In Capital	134,882	134,882	133,428	133,401	133,434	107,271
Retained Earnings	-123,147	-124,907	-91,382	-93,734	-60,603	-18,969
Treasury Stock	-3,707	-3,707	-3,707	-3,707	-3,707	-3,160
Comprehensive Income & Other	1,298	1,298	1,394	1,657	1,769	1,168
Total Common Equity	28,105	26,345	58,512	56,395	89,671	95,755
Minority Interest	-2,054	-1,888	471.81	1,355	2,188	2,949
Shareholders' Equity	29,308	27,520	61,691	60,144	91,859	98,704
Total Liabilities & Equity	91,631	90,500	133,618	166,844	224,121	215,448

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	25,200	27,655	40,440	74,015	87,009	74,186
Net Cash (Debt)	-17,034	-16,645	-18,003	-65,457	-33,224	-49,769
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-454.39	-444.58	-481.04	-1742.81	-1426.23	-2298.37
Filing Date Shares Outstanding	37.35	37.37	37.37	37.37	37.37	22.51
Total Common Shares Outstanding	37.35	37.37	37.37	37.37	37.37	22.51
Working Capital	-19,355	-21,030	-15,762	-61,937	-29,276	3,979
Book Value Per Share	752.49	704.99	1565.77	1509.11	2399.56	4254.76
Tangible Book Value	27,453	25,919	55,081	51,156	83,832	88,524
Tangible Book Value Per Share	735.03	693.59	1473.96	1368.91	2243.32	3933.45
Land	5,674	5,674	8,305	25,626	24,378	25,388
Buildings	38,867	38,860	47,346	52,384	52,053	50,835
Machinery	23,586	22,227	32,627	36,265	33,830	30,572
Construction In Progress	1,344	395.4	1,209	259.66	917.82	3,422

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error